P Müller|H G Dammann|B Simon - JoVE Visualize

Showing results (71-80 of 2,637) with videos related to

Pageof 264

Sort By:

Alimentary Pharmacology & Therapeutics|January 1, 1987

What are the current possibilities in treating peptic ulcer disease?H G Dammann, T A Walter, M Dreyer, et al.

Arzneimittel-Forschung|November 1, 1986

[The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man]H G Dammann, M Rehner, M Dreyer, et al.

Zeitschrift Fur Gastroenterologie|April 1, 1989

[Single evening administration of a new antimuscarinic agent telenzepine in therapy of acute duodenal ulcer. Results of a randomized double-blind comparative study versus pirenzepine]H G Dammann, M Dreyer, N Wolf, et al.

Schweizerische Medizinische Wochenschrift|May 12, 1984

[Human acid secretion during daily administration of H2-blockers]P Müller, B Simon, H G Dammann, et al.

Fortschritte Der Medizin|May 10, 1989

[Inhibition of 24-hour acidity by nizatidine]H G Dammann, M Dreyer, W R Gottlieb, et al.

Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987

The 24-hour acid suppression profile of nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.

Arzneimittel-Forschung|January 1, 1984

[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]C Staiger, B Koroknay, J X DeVries, et al.

Hepato-Gastroenterology|October 1, 1986

Nocturnal acid suppression with a new H2 receptor antagonist--nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.

Alimentary Pharmacology & Therapeutics|June 1, 1991

Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazoleW Londong, H Barth, H G Dammann, et al.

Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987

300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in EuropeB Simon, M Cremer, H G Dammann, et al.

Pageof 264

Showing results (71-80 of 2,637) with videos related to

Sort By:

Pageof 264

Alimentary Pharmacology & Therapeutics|January 1, 1987

What are the current possibilities in treating peptic ulcer disease?H G Dammann, T A Walter, M Dreyer, et al.

Arzneimittel-Forschung|November 1, 1986

[The action of various doses of the new imidazole H2-receptor antagonist etintidine on intragastric acidity in man]H G Dammann, M Rehner, M Dreyer, et al.

Zeitschrift Fur Gastroenterologie|April 1, 1989

[Single evening administration of a new antimuscarinic agent telenzepine in therapy of acute duodenal ulcer. Results of a randomized double-blind comparative study versus pirenzepine]H G Dammann, M Dreyer, N Wolf, et al.

Schweizerische Medizinische Wochenschrift|May 12, 1984

[Human acid secretion during daily administration of H2-blockers]P Müller, B Simon, H G Dammann, et al.

Fortschritte Der Medizin|May 10, 1989

[Inhibition of 24-hour acidity by nizatidine]H G Dammann, M Dreyer, W R Gottlieb, et al.

Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987

The 24-hour acid suppression profile of nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.

Arzneimittel-Forschung|January 1, 1984

[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human]C Staiger, B Koroknay, J X DeVries, et al.

Hepato-Gastroenterology|October 1, 1986

Nocturnal acid suppression with a new H2 receptor antagonist--nizatidineH G Dammann, W R Gottlieb, T A Walter, et al.

Alimentary Pharmacology & Therapeutics|June 1, 1991

Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazoleW Londong, H Barth, H G Dammann, et al.

Scandinavian Journal of Gastroenterology. Supplement|January 1, 1987

300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in EuropeB Simon, M Cremer, H G Dammann, et al.

Pageof 264